Ritwik Sinha
Title
Cited by
Cited by
Year
Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who …
K Porkka, HJ Khoury, RL Paquette, Y Matloub, R Sinha, JE Cortes
Cancer: Interdisciplinary International Journal of the American Cancer …, 2010
1722010
Dasatinib 2-year efficacy in patients with chronic-phase chronic myelogenous leukemia (CML-CP) with resistance or intolerance to imatinib (START-C)
MJ Mauro, M Baccarani, F Cervantes, JH Lipton, Y Matloub, R Sinha, ...
Journal of Clinical Oncology 26 (15_suppl), 7009-7009, 2008
972008
Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study
BA Rybicki, R Sinha, S Iyengar, C Gray-McGuire, RC Elston, MC Iannuzzi
Genes & Immunity 8 (5), 379-386, 2007
402007
Dasatinib time to and durability of major and complete cytogenetic response (MCyR and CCyR) in patients with chronic myeloid leukemia in chronic phase (CML-CP)
M Baccarani, G Rosti, G Saglio, J Cortes, R Stone, DW Niederwieser, ...
Blood, The Journal of the American Society of Hematology 112 (11), 450-450, 2008
362008
Predicting reactions to short-text posts
BV Srinivasan, A Natarajan, R Sinha, V Gupta, SV Revankar, B Ravindran
US Patent 9,256,826, 2016
342016
Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5
C Gray-McGuire, R Sinha, S Iyengar, C Millard, BA Rybicki, RC Elston, ...
Human genetics 120 (3), 420-430, 2006
322006
Dasatinib long-term efficacy in patients with chronic myeloid leukemia in chronic phase (CML-CP) with resistance or intolerance to imatinib: a two-year update of the START-C study
LTBY PLZF, RIS MEDIATED
Assistant Editors 93 (s1), 372, 2008
222008
Multiple testing in the genomics era: findings from Genetic Analysis Workshop 15, Group 15
LJ Martin, JG Woo, CL Avery, HS Chen, KE North, Group 15
Genetic epidemiology 31 (S1), S124-S131, 2007
182007
Dasatinib-Associated Major Molecular Responses Are Rapidly Achieved in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Following Resistance, Suboptimal …
A Hochhaus, MC Müller, J Radich, S Branford, B Hanfstein, P Rousselot, ...
Blood, The Journal of the American Society of Hematology 112 (11), 1095-1095, 2008
172008
A non-parametric approach to the multi-channel attribution problem
MM Yadagiri, SK Saini, R Sinha
International conference on web information systems engineering, 338-352, 2015
162015
Estimating the incremental effects of interactions for marketing attribution
R Sinha, S Saini, N Anadhavelu
2014 International Conference on Behavioral, Economic, and Socio-Cultural …, 2014
152014
Marketing channel attribution
R Sinha, SK Saini, N Anandhavelu
US Patent App. 14/508,141, 2016
132016
Probabilistic deduplication of anonymous web traffic
R Saha Roy, R Sinha, N Chhaya, S Saini
Proceedings of the 24th International Conference on World Wide Web, 103-104, 2015
132015
Identifying sources of anomalies in multi-variable metrics using linearization
SK Saini, R Sinha, M Rimer, N Anandhavelu
US Patent 10,404,777, 2019
122019
The affected-/discordant-sib-pair design can guarantee validity of multipoint model-free linkage analysis of incomplete pedigrees when there is marker-marker disequilibrium
C Xing, R Sinha, G Xing, Q Lu, RC Elston
The American Journal of Human Genetics 79 (2), 396-401, 2006
122006
Detecting differing categorical features when comparing segments
R Sinha, SK Saini, T Paulsen, M Rimer
US Patent 10,902,443, 2021
112021
Summarization and communication of large data sets
R Sinha, P Kumar, A Rohith, R Kateja
US Patent 10,088,974, 2018
92018
Optimal time to post for maximum social engagement
BV Srinivasan, N Anandhavelu, R Sinha, S Revankar
US Patent 9,607,273, 2017
92017
Prevalence of T315I, Dasatinib-Specific Resistant Mutations (F317L, V299L, and T315A), and Nilotinib-Specific Resistant Mutations (P-loop and F359) at the Time of Imatinib …
MWN Deininger, MJ Mauro, Y Matloub, R Sinha, L Ploughman, D Liu, ...
Blood, The Journal of the American Society of Hematology 112 (11), 3236-3236, 2008
92008
Haseman Elston regression in ascertained samples: Importance of dependent variable and mean correction factor selection
R Sinha, C Gray-McGuire
Human heredity 65 (2), 66-76, 2008
92008
The system can't perform the operation now. Try again later.
Articles 1–20